![Image Kevin Smith](https://cdn.zonebourse.com/images/author/equipeZB_G98.jpg)
Kevin Smith
News Writer
Discover our authors
Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease
The U.S. Food and Drug Administration has approved the marketing of two gene therapies for sickle cell disease, including the first treatment based on Crispr technology. These extremely costly treatments address a major medical need, affecting around 100,000 people in the USA alone.
December 11, 2023 at 04:17 pm IST
![British American Tobacco p.l.c. : Go smoke go broke](https://cdn.zonebourse.com/static/resize/464/261/https://www.zonebourse.com/images/ImagesTagged/zbimg_9194_800.jpg)
British American Tobacco p.l.c. : Go smoke go broke
Cigarette maker British American Tobacco plummets after unexpectedly taking a £25bn impairment charge. In a press release, it acknowledges that its fuel business has "no long-term future", and revises the book value of its brands accordingly.
December 07, 2023 at 09:18 pm IST
![The Liberty SiriusXM Group : John Malone's uppercuts and prophecies](https://cdn.zonebourse.com/static/resize/464/261/https://www.zonebourse.com/images/barons/john_malone_biographie.jpg)
The Liberty SiriusXM Group : John Malone's uppercuts and prophecies
In his traditional interview with journalist David Faber at the end of his group's annual general meeting, the famous media magnate delivered an unexpected uppercut to Patrick Drahi.
November 20, 2023 at 08:08 pm IST
Bayer AG : A difficult Sunday
The group's market capitalization fell by 15% at the opening of trading this morning, hit by the resounding failure of clinical trials for its new anticoagulant, coupled with a new legal condemnation linked to the side effects of glyphosate.
November 20, 2023 at 04:17 pm IST
- Stock Market
- Our authors
- Kevin Smith